advertisement

---

Lan C 10

Showing records 1 to 10 | Display all abstracts from Lan C

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Huang L
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Huang L
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Ye Q
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Wei Z
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Lan C
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Wang X
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Wang X
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Lan C
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Zhu Y
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Zhu Y; Ye Q
Biochemical Pharmacology 2022; 206: 115340

---